Medical Policy and Coding Updates - September 2021
This Premera medical policy and coding update lists changes from September 2021. Effective September 1, 2021, Keytruda was added for high-risk, early-stage triple negative breast cancer, and varicose vein procedures such as ligation and stripping and phlebectomy were removed from the varicose vein policy. Coding changes effective September 1, 2021 removed medical necessity and prior authorization review for varicose vein codes 37500 through 37785, and coding changes effective September 3, 2021 added medical necessity and prior authorization review for alpha1-proteinase inhibitor codes J0256 and J0257 and gonadotropin releasing hormone analog codes J1950 through J9226.